Dynamic Technology Lab’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Dynamic Technology Lab’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-9,641	Closed	-$418K	–	1589
2020 Q4	$418K	Buy	+9,641	New	+$475K	0.07%	520
2020 Q3	–	Sell	-4,279	Closed	-$270K	–	1448
2020 Q2	$270K	Buy	+4,279	New	+$293K	0.04%	705
2019 Q4	–	Sell	-8,600	Closed	-$417K	–	1403
2019 Q3	$417K	Buy	+8,600	New	+$448K	0.07%	506
2018 Q4	–	Sell	-9,734	Closed	-$370K	–	1418
2018 Q3	$370K	Buy	+9,734	New	+$431K	0.05%	658
2018 Q2	–	Sell	-7,328	Closed	-$354K	–	1416
2018 Q1	$354K	Buy	+7,328	New	+$409K	0.05%	633
2017 Q4	–	Sell	-6,627	Closed	-$205K	–	1436
2017 Q3	$205K	Buy	+6,627	New	+$186K	0.03%	904

Other funds holding GBT

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dynamic Technology Lab's GBT Position: Q1 2021 in Review

Dynamic Technology Lab sold out of Global Blood Therapeutics, Inc. (GBT) in Q1 2021, closing a stake of 9,641 shares — an estimated $418K sold.

Dynamic Technology Lab first reported a position in GBT in Q3 2017 and held it in 6 quarters. The position peaked at $418K in Q4 2020. 214 funds tracked by Wall St. Rank hold GBT as of Q1 2021.

Dynamic Technology Lab reported no remaining Global Blood Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
Dynamic Technology Lab sold 9,641 Global Blood Therapeutics, Inc. shares in Q1 2021, an estimated $418K.
Dynamic Technology Lab first reported a position in Global Blood Therapeutics, Inc. in Q3 2017 and held it in 6 quarters.
Dynamic Technology Lab's Global Blood Therapeutics, Inc. position peaked at $418K in Q4 2020.
214 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2021.

Based on Dynamic Technology Lab's 13F filing for Q1 2021, filed 14 May 2021.